Set to create 30 new jobs over the next two years, the investment, awarded by the Welsh Assembly Government through Regional Selective Assistance grant aid, will enable Penn to build four new clean rooms, improve its packaging suites and enhance its laboratory facilities. Craig Rennie, chief executive at Penn, commented; "This is great news for Penn and comes following a period of considerable growth and development. So far this year, Penn has made ten appointments in various roles within the business, including the appointment of Peter George as chief operating officer, and over the past six years has created a total of 80 new jobs at our site in Tredegar. In addition to this, Penn reported strong sales figures for the fifth consecutive year in 2005 with a 10% increase against the same period the previous year. The grant, facilitated by Broomfield Alexander, of £250,000 forms part of a strategically important expansion for Penn and allows the company to continue to differentiate ourselves as a fully integrated service provider." Penn Pharmaceutical Services Ltd is a leading provider of outsourced pharmaceutical development services to the international healthcare industry. The company’s core business expertise includes a fully comprehensive product development service, which consists of formulation and analytical development, clinical trial manufacturing, packaging and supply management and extensive contract manufacturing. Penn also offers CMC Consultancy and Qualified Person (QP) Services.